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CANCER CONTROL RELATED TO STIMULATION OF IMMUNITY BY 
LOW-DOSE RADIATION
Shu-Zheng Liu  Department of Radiation Biology, Jilin University School of
Public Health, 8 Xinmin Street, Changchun 130021, China, drliusz@yahoo.com
 Previous studies showed that low dose radiation (LDR) could stimulate the immune
system in both animal and human populations. This paper reviews the present status of
relevant research as support to the use of LDR in clinical practice for cancer prevention
and treatment. It has been demonstrated that radiation-induced changes in immune activ-
ity follows an inverse J-shaped curve, i.e., low dose stimulation and high dose suppression.
The stimulation of immunity by LDR concerns most anticancer parameters, including
antibody formation, natural killer activity, secretion of interferon and other cytokines as
well as other cellular changes. Animal studies have revealed that LDR retards tumor
growth, decreases cancer metastasis, and inhibits carcinogenesis induced by high dose
radiation. These effects of LDR on cancer control were found to be related to its stimula-
tion on immunity. The experimental data may well explain the efficacy of the clinical trial
of LDR in the treatment of cancer. 
I. INTRODUCTION
Carcinogenesis induced by environmental agents is a problem of con-
cern to the public and scientific bodies. Ionizing radiation is one among
these environmental agents. It is well known that most carcinogens are
immunosuppressants. Ionizing radiation is one of these when delivered at
moderate to high doses. Immune surveillance is one of the most impor-
tant defense mechanisms in the body monitoring the development of
cancer. As reviewed in previous reports low dose radiation (LDR)
enhances immune functions.(1, 2) The significance of these immunologic
changes in radiation-induced cancer is still a question of debate. In
UNSCEAR 1994, it is stated, “the immune system may not play a major
role in moderating human radiation oncogenesis, although immune
function in certain organs may ensure that some early neoplastic cells are
eliminated before they become established”.(3) NCRP Report No. 136
states, “in the ultimate instance of cancer in vivo, the adaptive response
may take the form of an immune surveillance of pre-neoplastic cells. This
is certainly a possibility, but it is difficult to design laboratory experiments
to test it”. (4) In a recent commentary article on radiation hormesis, it is
recognized that “under appropriate conditions, exposure to X-rays or
gamma rays at doses below those causing immunosuppressive effects has
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been observed to augment various immune responses in mice...” but “the
mechanisms of the observed enhancement remain to be elucidated in
full...”.(5) These statements accept the importance of experimental data
on LDR-induced enhancement of immunity and its surveillance of cancer
formation on one hand and question its significance in cancer control on
the other. 
There have been accumulating data disclosing the cellular and molec-
ular mechanisms of LDR-induced activation of anti-tumor immunity in
animal models, as reviewed in Reference 1. LDR increases cellular antiox-
idant activity; facilitates DNA damage repair; reduces malignant transfor-
mation and mutagenesis, and stimulates immune surveillance.(6-10) All
these may contribute to the effect of LDR on the reduction of cancer inci-
dence. There have been experimental studies illustrating: a) the suppres-
sive effect of LDR on tumor growth, metastasis and carcinogenesis, b) the
increased anti-cancer immunity, including enhanced NK and CTL activity,
and c) the increased IFNγ and IL-2 secretion. All these data point to the
significance of enhanced immune responses in cancer control.(11-23)
II. LOW DOSE RADIATION AND IMMUNITY
Stimulation of immunity by low dose radiation is manifested in vari-
ous aspects.(1) Table 1 shows the immunologic parameters studied in the
author’s laboratory demonstrating up-regulation of immune functions in
animal models exposed to single as well chronic irradiation.(24-36) As illus-
trated in this table, most immunologic parameters are stimulated after
whole-body irradiation (WBI) by doses within 0.1 Gy, using a dose-rate
within 15 mGy/min. The NK (natural killer) activity of splenocytes was
assessed with the 125I-UdR release method using YAC-1 cells as targets in
C57BL/6J mice. Significant stimulation was observed after WBI with both
75 and 500 mGy. For most immunologic parameters of splenocytes, doses
above 500 mGy may exert an inhibitory effect. But with NK activity, 500
mGy showed an even higher stimulatory effect than 75 mGy. This is obvi-
ously related to the relatively higher radio-resistance of the NK cells. This
is also the case with macrophages. WBI with 75 mGy caused a 32%
increase of the secretion of IL-12 (see Table 1), with higher increases
after doses above 1 Gy (not shown). The inhibitory effect of peritoneal
macrophages on the growth of tumor cell line S180 was increased by 52%
after WBI with 75 mGy. The specific CTL activity was assayed in C57BL/6J
mice bearing Lewis lung carcinoma; a 40% increase of cancer suppressive
effect was observed. The ADCC (antibody-dependent cell-mediated cyto-
toxicity) activity is a specific reaction to P815 cancer cells, assessed with
the 125I-UdR release method. These four parameters are directly related
to anticancer immunity. The PFC (plaque forming cell) reaction denotes
the capacity of antibody formation in response to sheep RBC as antigen.
This is a T-dependent reaction, which was found to be stimulated by both
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acute and chronic low dose radiation. Under very low dose rate, 15
μGy/min, a cumulative dose of 65 mGy increased the response signifi-
cantly – by 16%. The measurement of T cell proliferation is an indication
of activation and clonal expansion of the T lymphocytes, representing
immune activation. Four sets of data are shown in Table 1, the first two of
which are from experiments on Balb/c mice. These mice are relatively
sensitive to ionizing radiation. The third and fourth sets of data are from
Kunming mice, which show a response to ionizing radiation comparable
to that of C57BL/6J mice, as tested in our laboratory. It is interesting to
note that after an acute dose of 75-106 mGy, at the dose rate of 12.5-12.7
mGy/min, both strains of mice responded with an increase in T cell pro-
liferation of more than 100%. However, for the Balb/c mice, this dose
would have no effect in T cell proliferation if the dose rate were 200
mGy/min.(32) Other authors have also noted this strain difference of lym-
TABLE 1. Immune functions stimulated by low dose radiation in mice
Immunologic Dose-rate 
Parameter Dose (mGy) (mGy/min) Change (%) P value  
NK activity 75 12.5 +19 <0.05 (28)
500 510 +45 <0.01 (28)
Mac activity1 75 12.5 +52 <0.05 (33)
CTL2 75 12.5 +40 <0.01 (13)
ADCC3 75 12.5 +31 <0.05 (31)
PFC reaction4 75 12.5 +74 <0.05 (47)
65 15 (µGy/min) +16 <0.05 (47)
100 12.5 +50 <0.05 (31) 
T cell proliferation5 77 12.7 +101 <0.01 (32)
106 12.7 +101 <0.01 (32)
75 12.5 +130 <0.01 (27) 
75 12.5 +142 <0.01 (25)
G-CSF secretion6 50 12.5 +58 <0.01 (33)
75 12.5 +52 <0.01 (33)
100 12.5 +42 <0.05 (33)
IFNγ secretion 75 12.5 +30 <0.05 (26)
100 12.5 +31 <0.05 (26)
IL-2 secretion 75 12.5 +33(d2) <0.05 (31)
75 12.5 +66(d7) <0.05 (31)
IL-10 secretion 75 12.5 –61 <0.01 (35)
IL-12 secretion 75 12.5 +32 <0.05 (36)
IL-18 secretion 75 12.5 +90(24h) <0.05 (pc)
75 12.5 +185(48h) <0.01 (pc)
TNFα secretion 75 12.5 +358 <0.01 (30)
IL-1β secretion 75 12.5 +72 <0.01 (31)
All data represent experimental results obtained 24h after LDR except otherwise specified. 1.
Macrophage antitumor activity assayed with S180 cells; 2. Specific cytolytic T lymphocyte activity of
splenocytes assayed with Lewis lung cancer cells; 3. Antibody-dependent cell-mediated cytotoxicity of
splenocytes assayed with P815 cells; 4. Mice were immunized with sheep RBC on day 4 after WBI and
plaque-forming cells were counted on day 9; 5. T cell proliferation was measured with 3H-TdR incor-
poration in the presence of Con A 5 μg/ml; 6. G-CSF was assayed with RIA. Reference numbers are
given in parenthesis; pc=personal communication).
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phocyte proliferation in response to radiation.(37) The secretion of
cytokines was stimulated in favor of differentiation of the TH1 subset.
Activation of T lymphocytes is related to the up-regulation of surface mol-
ecules CD2, CD3 and CD28 after LDR.(1, 2, 27, 38) In response to these
changes, intracellular signal transduction is facilitated.(39-44) Among
these, the up-regulation of PKC and [Ca2+]i forms the most important
intracellular molecular basis of T lymphocyte stimulation (Table 2).
III. EFFECT OF LOW DOSE RADIATION ON CANCER CONTROL(11-23)
It was shown that irradiation with low dose X-rays decreased the
growth rate and metastasis of implanted B16 melanoma and Lewis lung
cancer in C57BL/6J mice. As shown in Figure 1, the effect of WBI with
0.075 Gy (given 24h before implantation of Lewis lung cancer cells) on
tumor growth is manifested as: decrease in tumor size by ~50% (column
1); increase in mean survival time by ~40% (column 2), and decrease of
30-day mortality rate by ~40% (column 3).(11, 18, 31)
TABLE 2. Important Intracellular signal molecules stimulated by low dose radiation1
Signal Molecule Dose (mGy) Dose-rate (mGy/min) Change (%) P value
[Ca2+]i 75 12.5 +133 <0.001 
Calcineurin 75 12.5 +70 <0.01 
PKCα 75 12.5 +54 <0.001 
PKCβ1 75 12.5 +163 <0.001
PKCβ2 75 12.5 +72 <0.01
1 Changes occurring in thymocytes 24h after WBI with 75 mGy; [Ca2+]i was measured in the pres-
ence of 5 μg/ml of Con A. Methods are given in references 39 and 41.
FIGURE 1. Effect of low dose radiation on Lewis lung cancer (0.075 Gy WBI, 24 h before tumor
implantation)
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Figure 2 shows the reduction of pulmonary metastasis of B16
melanoma cells after WBI with 0.05-0.15 Gy (intravenous injection of B16
cells 24 h after irradiation, showing significant reduction of lung nodules
of cancer cells 14d after injection)(12, 14, 15). Figure 3 shows the effect of
LDR on the efficacy of mitomycin C (3 mg/kg body weight) on the
growth of Lewis lung cancer cells implanted to mice. WBI with 0.075 Gy,
6 h before chemotherapy, further reduced the tumor size (column 3 com-
pared to column 2)(16, 17, 23). Figure 4 shows the alleviation of immune sup-
pression caused by tumor burden (Lewis lung cancer implantation) by
LDR, as demonstrated by the recovery of the lowered NK activity after
LDR in tumor-bearing mice.(13)
FIGURE 2. Low dose radiation reduces cancer metastasis (Injection of B16 cells, i.v., 24 h after WBI
with different doses of X-rays)
FIGURE 3. Low dose radiation increases efficacy of cancer chemotherapy
5
Liu: Cancer control related to stimulation of immunity by low-dose radiation
Published by ScholarWorks@UMass Amherst, 2014
S.-Z. Liu
44
In a well recognized model of thymic lymphoma, induced by frac-
tionated WBI (1.75 Gy once a week for 4 consecutive weeks) in C57BL/6J
mice, a low dose of radiation (0.075 Gy), 6-12 hours preceding each frac-
tionated high dose radiation (HDR), could reduce the lymphoma inci-
dence from 43.3% in the control (exposed to only the HDR) to 15.1%
(HDR being preceded by 0.075 Gy with an interval of 6h) and 17.6%
(HDR being preceded by 0.075 Gy with an interval of 12h) in 6 months
after the fractionated exposures. These inhibitory effects of LDR on can-
cer growth and cancer induction are accompanied with immunologic
stimulation.(11, 19, 21, 22)
Clinical application of LDR in the treatment of cancer has shown
enlightening results. When patients with non-Hodgkin’s lymphoma under
chemotherapy were given total body or half body (to the thorax) LDR in
a regimen of 0.1 Gy 3 times a week or 0.15 Gy 2 times a week for 5 con-
secutive weeks with a total dose of 1.5 Gy, the survival rate in 9 years rose
to 84% from 50% of the control with chemotherapy alone (P < 0.01). The
LDR-treated patients also showed enhanced anti-cancer immunity.[45]
In an area of high natural radioactivity with the exposure rate 3 times
as high as that in the adjacent control area in south China with epidemi-
ological survey having been continued for 31 years, the cancer mortality
rate was found to be slightly lower than that among the inhabitants in the
control area.(46) Examination of the peripheral blood of the inhabitants
showed increased reactivity of the lymphocytes to PHA and enhanced
DNA damage repair capability as shown by increased UDS of the lym-
phocytes.(47) There were increased chromosome aberrations in the blood
samples implicating DNA damage.(46) It is supposed that the balance
between radiation damage and defense mechanisms under this circum-
stance results in no increase or even lowering of cancer mortality in spite
of the long term exposure of the inhabitants to the low level radiation.
FIGURE 4. Low dose radiation stimulates immunity in tumor-bearing mice
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IV. CONCLUDING REMARKS
The stimulation of immunity by LDR concerns most anticancer
parameters, including antibody formation, NK activity, CTL activity,
macrophage activity, ADCC activity, secretion of interferon and other
cytokines as well as other cellular changes. Animal studies have revealed
that LDR retards tumor growth, decreases cancer metastasis, and inhibits
carcinogenesis induced by high dose radiation. These effects of LDR on
cancer control were found to be related to its stimulation on immunity.
The experimental data may well explain the efficacy of the clinical use of
LDR in the treatment of cancer. This paper reviews the present status of
relevant research on effects of low dose radiation on anticancer immuni-
ty as support to its trial in clinical practice.
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